Pri-Med New York

New York City, NY | November 12-13, 2020

Jacob K. Javits Convention Center

Disclosures

The following relevant financial relationships have been disclosed by faculty:

Financial Disclosures

Peng Thim Fan, MD, FACP
Abbvie, Speakers Bureau; Amgen, Speakers Bureau; Exagen, Advisory Board; Novartis, Speakers Bureau; Pfizer, Speakers Bureau; Radius, Speakers Bureau; Regeneron, Speakers Bureau; Sanofi Genzyme, Speakers Bureau
Robert H. Hopkins, Jr, MD, MACP, FAAP
No financial disclosures
Pamela Kushner, MD, FAAFP
AstraZeneca, Advisory Board; AstraZeneca, Consultant; AstraZeneca, Speakers Bureau; Bristol-Myers Squibb, Advisory Board; Janssen Pharmaceuticals, Inc., Advisory Board; Janssen Pharmaceuticals, Inc., Consultant; Janssen Pharmaceuticals, Inc., Speakers Bureau; Lilly USA, LLC, Advisory Board; Novo Nordisk Inc., Advisory Board; Pfizer, Advisory Board
Howard Libman, MD
No financial disclosures
Lee A. Lindquist, MD, MPH, MBA
No financial disclosures
Salvatore Mangione, MD
No financial disclosures
Edward M. Phillips, MD
No financial disclosures
Jeff Unger, MD, FAAFP, FACE
Abbott Laboratories, Advisory Board; Abbott Laboratories, Contracted Research; Abbott Laboratories, Speakers Bureau; Amgen Inc., Speakers Bureau; GlaxoSmithKline, Contracted Research; Janssen Pharmaceuticals, Inc., Advisory Board; Janssen Pharmaceuticals, Inc., Contracted Research; Janssen Pharmaceuticals, Inc., Speakers Bureau; Novo Nordisk Inc., Advisory Board; Novo Nordisk Inc., Contracted Research; Novo Nordisk Inc., Ownership Interest; Novo Nordisk Inc., Speakers Bureau
Charles Vega, MD, FAAFP
Genentech (Nov. 2019), Speakers Bureau; GlaxoSmithKline, Advisory Board
Shirah Vollmer, MD
No financial disclosures

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board and Speaker's Bureau for AstraZeneca, GlaxoSmithKline, and Janssen Pharmaceuticals, Inc.; Consulting Fee and Services Provided for Promotional Purposes for AstraZeneca and Janssen Pharmaceuticals. 

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.